A detailed history of Squarepoint Ops LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Squarepoint Ops LLC holds 64,674 shares of TAK stock, worth $851,756. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,674
Holding current value
$851,756
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.0 - $15.08 $840,762 - $975,283
64,674 New
64,674 $919,000
Q1 2024

May 15, 2024

BUY
$13.89 - $15.04 $578,601 - $626,506
41,656 Added 165.93%
66,760 $927,000
Q4 2023

Feb 14, 2024

BUY
$13.36 - $15.43 $335,389 - $387,354
25,104 New
25,104 $358,000
Q1 2023

May 15, 2023

BUY
$15.28 - $16.48 $735,120 - $792,852
48,110 New
48,110 $792,000
Q1 2022

May 16, 2022

SELL
$13.54 - $15.35 $335,291 - $380,112
-24,763 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $326,128 - $406,113
24,763 New
24,763 $338,000
Q3 2021

Nov 15, 2021

SELL
$16.3 - $17.26 $216,398 - $229,143
-13,276 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$16.55 - $18.64 $78,662 - $88,595
-4,753 Reduced 26.36%
13,276 $223,000
Q1 2021

May 17, 2021

BUY
$16.71 - $19.9 $301,264 - $358,777
18,029 New
18,029 $329,000
Q4 2020

Feb 16, 2021

SELL
$15.39 - $18.97 $576,109 - $710,122
-37,434 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$17.1 - $19.19 $640,121 - $718,358
37,434 New
37,434 $668,000
Q1 2020

May 15, 2020

SELL
$13.02 - $20.31 $171,186 - $267,035
-13,148 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$16.88 - $20.83 $221,938 - $273,872
13,148 New
13,148 $259,000
Q2 2019

Aug 14, 2019

SELL
$16.58 - $20.49 $187,038 - $231,147
-11,281 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$16.7 - $21.52 $188,392 - $242,767
11,281 New
11,281 $230,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.9B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.